GSK315234 is a humanized anti-OSM IgG monoclonal antibody developed for the treatment of patients with active rheumatoid arthritis (RA), designed to bind to the Site II region of OSM and prevent dimerization with gp130 (236). This evidence concerns the gene IL6ST and rheumatoid arthritis.